Search
Uptake of CAR T cell therapy in Europe
Gene (editing) therapy continues to break ground in hematology, showing promising results in tackling severe blood cancers. Yet, its uptake in the European Union is slow, with few patients benefiting from it so far.
Read moreHealth Technology Assessment (HTA)
Every European citizen should have access to the best quality medical care at the best possible price. Pan-European cooperation on health technology assessments (HTA) is essential for such aspirations.
Read moreMeet Fabienne Lucas, our January Volunteer of the Month
EHA is a Public Benefit Organization under Dutch law.
Read moreMeet Fabienne Lucas, our January Volunteer of the Month
EHA is a Public Benefit Organization under Dutch law.
Read moreFirst CMML guidelines produced by EHA, now available
Chronic myelomonocytic leukemia (CMML) is a rare disease with overlapping features of two categories of bone marrow and blood cell disorders that poses challenges in clinical management.
Read moreNobel prize goes to immunotherapy researchers
October 1, Sweden - Cancer kills millions of people every year and is one of humanity’s greatest health challenges.
Read moreMajor changes needed for patients to benefit from precision medicine
Precision medicine approaches the treatment of a disease via an individual’s genes, environment, and lifestyle.
Read more